Nal–Anti TIGIT (TuHURA Biosciences)

N/A

Report date: 2025/02/21 16:20:25

Base Information

Drug NameNal–Anti TIGIT (TuHURA Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsδ-opioid receptor antagonists
TargetsT cell immunoglobulin and ITIM domainsδ-opioid receptor
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKintara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKintara Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A